DCS Pharma Targets Italian APIs By Acquiring Chemsource And Gopharma
API specialist DCS Pharma has broken into the “key market” of Italy by acquiring Chemsource and Gopharma.
You may also be interested in...
Cambrex is set to invest approximately US$3 million in its Paullo plant in Milan, Italy, to “increase the capacity and efficiency” of the intermediates and active pharmaceutical ingredients (APIs) site.
Paracetamol, opioids and non-steroidal anti-inflammatory drugs are among the common medicines that “can do more harm than good” and should not be used for managing chronic primary pain, according to a draft NICE guideline.
Sandoz is seeking an en banc rehearing of a recent appeals court decision that stands to keep its Erelzi biosimilar etanercept rival to Enbrel off the market until 2029 in the US, claiming that the ruling provides a “playbook” for originators to extend patents beyond their legitimate terms.